Exploratory Assessment: Nurse-led Community Health Worker Delivered HCV Intervention for People Experiencing Homelessness

Overview

Journal Public Health Nurs

Date 2023 May 3

PMID 37132164

Authors

Adeline Nyamathi

Benissa E Salem

Darlene Lee

Zhaoxia Yu

Angela Hudson

Sammy Saab

Sanghyuk S Shin

Alexandria Jones-Patten

Kartik Yadav

Mitra Alikhani

Richard Clarke

Alicia Chang

Kathryn White

Lillian Gelberg

Affiliations

Soon will be listed here.

Abstract

Background: Getting and maintaining Hepatitis C Virus (HCV) cure is challenging among people experiencing homelessness (PEH) as a result of critical social determinants of health such as unstable housing, mental health disorders, and drug and alcohol use.

Objectives: The purpose of this exploratory pilot study was to compare a registered nurse/community health worker (RN/CHW)-led HCV intervention tailored for PEH, "I am HCV Free," with a clinic-based standard of care (cbSOC) for treating HCV. Efficacy was measured by sustained virological response at 12 weeks after stopping antivirals (SVR12), and improvement in mental health, drug and alcohol use, and access to healthcare.

Methods: An exploratory randomized controlled trial design was used to assign PEH recruited from partner sites in the Skid Row Area of Los Angeles, California, to the RN/CHW or cbSOC programs. All received direct-acting antivirals. The RN/CHW group received directly observed therapy in community-based settings, incentives for taking HCV medications, and wrap-around services, including connection to additional healthcare services, housing support, and referral to other community services. For all PEH, drug and alcohol use and mental health symptoms were measured at month 2 or 3 and 5 or 6 follow-up, depending on HCV medication type, while SVR12 was measured at month 5 or 6 follow-up.

Results: Among PEH in the RN/CHW group, 75% (3 of 4) completed SVR12 and all three attained undetectable viral load. This was compared with 66.7% (n = 4 of 6) of the cbSOC group who completed SVR12; all four attained undetectable viral load. The RN/CHW group, as compared to the cbSOC, also showed greater improvements in mental health, and significant improvement in drug use, and access to healthcare services.

Discussion: While this study shows significant improvements in drug use and health service access among the RN/-CHW group, the sample size of the study limits the validity and generalizability of the results. Further studies using larger sample sizes are necessitated.

References

Pateria P, De Boer B, MacQuillan G . Liver abnormalities in drug and substance abusers. Best Pract Res Clin Gastroenterol. 2013; 27(4):577-96. DOI: 10.1016/j.bpg.2013.08.001. View

Arum C, Fraser H, Artenie A, Bivegete S, Trickey A, Alary M . Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021; 6(5):e309-e323. PMC: 8097637. DOI: 10.1016/S2468-2667(21)00013-X. View

Beiser M, Smith K, Ingemi M, Mulligan E, Baggett T . Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston. Int J Drug Policy. 2019; 72:129-137. DOI: 10.1016/j.drugpo.2019.03.017. View

Leach M, Chapin S, Porges I, Portner S, Charest T, Downing J . Evaluation of Risk Factors for Hepatitis C Virus Infection Among Philadelphia's Shelter-Bound, Homeless Population: Data from a Student-Run Hepatitis C Virus Screening Initiative. Popul Health Manag. 2020; 24(4):448-453. DOI: 10.1089/pop.2020.0143. View

Noska A, Belperio P, Loomis T, OToole T, Backus L . Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans. Clin Infect Dis. 2017; 65(2):252-258. PMC: 6248754. DOI: 10.1093/cid/cix295. View

Stone J, Artenie A, Hickman M, Martin N, Degenhardt L, Fraser H . The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study. Lancet Public Health. 2022; 7(2):e136-e145. PMC: 8848679. DOI: 10.1016/S2468-2667(21)00258-9. View

Bush H, Paik J, Golabi P, de Avila L, Escheik C, Younossi Z . Impact of hepatitis C virus and insurance coverage on mortality. Am J Manag Care. 2019; 25(2):61-67. View

Berwick D, Murphy J, Goldman P, Ware Jr J, Barsky A, Weinstein M . Performance of a five-item mental health screening test. Med Care. 1991; 29(2):169-76. DOI: 10.1097/00005650-199102000-00008. View

Singh A, Daniel L, Baker E, Bentley R . Housing Disadvantage and Poor Mental Health: A Systematic Review. Am J Prev Med. 2019; 57(2):262-272. DOI: 10.1016/j.amepre.2019.03.018. View

10.

Burgess S, Hussaini T, Yoshida E . Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: A concise review. Ann Hepatol. 2016; 15(2):154-9. DOI: 10.5604/16652681.1193693. View

11.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

12.

Ward K, McCormick S, Sulkowski M, Latkin C, Chander G, Falade-Nwulia O . Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration. Int J Drug Policy. 2020; 88:103019. PMC: 8005423. DOI: 10.1016/j.drugpo.2020.103019. View

13.

Skeer M, Ladin K, Wilkins L, Landy D, Stopka T . 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend. 2018; 190:246-254. PMC: 6367928. DOI: 10.1016/j.drugalcdep.2018.06.013. View

14.

Paisi M, Crombag N, Burns L, Bogaerts A, Withers L, Bates L . Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed-methods systematic review. Health Expect. 2021; 25(1):48-60. PMC: 8849376. DOI: 10.1111/hex.13400. View

15.

Nyamathi A . Comprehensive health seeking and coping paradigm. J Adv Nurs. 1989; 14(4):281-90. DOI: 10.1111/j.1365-2648.1989.tb03415.x. View

16.

Benitez T, Fernando S, Amini C, Saab S . Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row. Dig Dis Sci. 2020; 65(10):3023-3031. DOI: 10.1007/s10620-020-06073-0. View

17.

Osna N, Donohue Jr T, Kharbanda K . Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017; 38(2):147-161. PMC: 5513682. View

18.

. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013; 62(18):362-5. PMC: 4605020. View

19.

Salari N, Kazeminia M, Hemati N, Ammari-Allahyari M, Mohammadi M, Shohaimi S . Global prevalence of hepatitis C in general population: A systematic review and meta-analysis. Travel Med Infect Dis. 2022; 46:102255. DOI: 10.1016/j.tmaid.2022.102255. View

20.

Asselah T, Hezode C, Qaqish R, Elkhashab M, Hassanein T, Papatheodoridis G . Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial. Lancet Gastroenterol Hepatol. 2017; 1(1):25-35. DOI: 10.1016/S2468-1253(16)30001-2. View